{"id":"W3135328828","doi":"10.1200/jco.2021.39.6_suppl.13","title":"PI3K/AKT pathway biomarkers analysis from the phase III IPATential150 trial of ipatasertib plus abiraterone in metastatic castration-resistant prostate cancer.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"PTEN; Medicine; Prostate cancer; Immunohistochemistry; Internal medicine; Cancer; Population; Oncology; Abiraterone acetate; Pathology; PI3K/AKT/mTOR pathway; Androgen deprivation therapy; Apoptosis; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003009342,0.00109263,0.001429172,0.00044535,0.0002138572,0.0009371588,0.0006927464,0.0004746947,0.00434143],"category_scores_gemma":[0.001692149,0.0003333649,0.002278302,0.0007558164,0.0004507285,0.0004607758,0.000516058,0.001379225,0.0006770245],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000644757,"about_ca_system_score_gemma":0.001397245,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007638886,"about_ca_topic_score_gemma":0.003889323,"domain_scores_codex":[0.9991448,0.0004139653,0.00005827459,0.0001425594,0.0001528021,0.00008764853],"domain_scores_gemma":[0.999212,0.0001514993,0.000290867,0.00007606795,0.0000754477,0.0001940615],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7946144,0.004308701,0.0635746,0.002856921,0.01639776,0.0002159207,0.0001632362,0.003341633,0.01563036,0.0005121828,0.01123841,0.08714589],"study_design_scores_gemma":[0.5232771,0.1525319,0.2692404,0.0003793181,0.02762187,0.001417726,0.000165897,0.003349567,0.005824415,0.001082723,0.01499187,0.0001172309],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9705047,0.007254145,0.001014858,0.0006045585,0.0001123812,0.001989675,0.01224334,0.0001345424,0.006141782],"genre_scores_gemma":[0.9678592,0.002224113,0.0014736,0.0007805919,0.0001451257,0.001803453,0.02339935,0.0000302265,0.002284384],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00434143,"threshold_uncertainty_score":0.0159151,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.200979632659316,"score_gpt":0.5116480651843357,"score_spread":0.3106684325250197,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}